Tempest Therapeutics, Inc. Net Cash Provided by (Used in) Continuing Operations
Tempest Therapeutics, Inc. (TPST) reported Net Cash Provided by (Used in) Continuing Operations of $16.21 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2018-11-09
- Tempest Therapeutics, Inc. net cash provided by (used in) continuing operations for the quarter ending 2018-09-30 was $7.32M, a 303.14% increase year-over-year.
- Tempest Therapeutics, Inc. net cash provided by (used in) continuing operations for the quarter ending 2018-06-30 was $4.88M.
- Tempest Therapeutics, Inc. net cash provided by (used in) continuing operations for the quarter ending 2018-03-31 was $4.02M.
- Tempest Therapeutics, Inc. net cash provided by (used in) continuing operations for the quarter ending 2017-12-31 was -$9.42M.
- Tempest Therapeutics, Inc. net cash provided by (used in) continuing operations for fiscal 2017 was -$28.23M, a 4098.16% decline from fiscal 2016.
- Tempest Therapeutics, Inc. net cash provided by (used in) continuing operations for fiscal 2016 was $706.00K, a 98.08% decline from fiscal 2015.
- Tempest Therapeutics, Inc. net cash provided by (used in) continuing operations for fiscal 2015 was $36.81M.
- Tempest Therapeutics, Inc. net cash provided by (used in) continuing operations for fiscal 2014 was -$11.66M, a 453.24% decline from fiscal 2013.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Continuing Operations 12 month | Net Cash Provided by (Used in) Continuing Operations 15 month | Net Cash Provided by (Used in) Continuing Operations 18 month | Net Cash Provided by (Used in) Continuing Operations 21 month | Net Cash Provided by (Used in) Continuing Operations 24 month | Net Cash Provided by (Used in) Continuing Operations 27 month | Net Cash Provided by (Used in) Continuing Operations 30 month | Net Cash Provided by (Used in) Continuing Operations 33 month | Net Cash Provided by (Used in) Continuing Operations 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | $7.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $12.19M derived: sum of 2 quarters · filed 2018-11-09 | $16.21M 10-Q · filed 2018-11-09 | $6.79M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||||
| 2018-06-30 | $4.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $8.90M 10-Q · filed 2018-08-09 | -$525.00K derived: sum of 3 quarters · filed 2018-08-09 | $1.29M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||||
| 2018-03-31 | $4.02M 10-Q · filed 2018-05-03 | -$5.40M derived: sum of 2 quarters · filed 2018-05-03 | -$3.59M derived: sum of 3 quarters · filed 2018-11-09 | -$5.71M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||||
| 2017-12-31 | -$9.42M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$7.61M derived: sum of 2 quarters · filed 2018-11-09 | -$9.73M derived: sum of 3 quarters · filed 2018-11-09 | -$28.23M 10-K · filed 2018-03-15 | ||||||||||
| 2017-09-30 | $1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$308.00K derived: sum of 2 quarters · filed 2018-11-09 | -$18.80M 10-Q · filed 2018-11-09 | -$19.16M 10-Q · filed 2017-11-02 | -$25.36M derived: sum of 4 quarters · filed 2018-11-09 | |||||||||
| 2017-06-30 | -$2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$20.62M 10-Q · filed 2018-08-09 | -$20.99M 10-Q · filed 2017-08-03 | -$27.17M derived: sum of 3 quarters · filed 2018-08-09 | -$72.58M derived: sum of 4 quarters · filed 2018-08-09 | |||||||||
| 2017-03-31 | -$18.50M 10-Q · filed 2018-05-03 | -$25.05M derived: sum of 2 quarters · filed 2018-05-03 | -$70.46M derived: sum of 3 quarters · filed 2018-05-03 | $4.96M derived: sum of 4 quarters · filed 2018-05-03 | ||||||||||
| 2016-12-31 | -$6.55M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$51.96M derived: sum of 2 quarters · filed 2018-03-15 | $23.45M derived: sum of 3 quarters · filed 2018-03-15 | $706.00K 10-K · filed 2018-03-15 | ||||||||||
| 2016-09-30 | -$45.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $30.00M derived: sum of 2 quarters · filed 2017-11-02 | $7.26M 10-Q · filed 2017-11-02 | -$362.00K derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||
| 2016-06-30 | $75.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $52.67M 10-Q · filed 2017-08-03 | $45.05M derived: sum of 3 quarters · filed 2018-03-15 | $25.66M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||
| 2016-03-31 | -$22.75M 10-Q · filed 2017-05-09 | -$30.36M derived: sum of 2 quarters · filed 2018-03-15 | -$49.76M derived: sum of 3 quarters · filed 2018-03-15 | -$114.22M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||
| 2015-12-31 | -$7.62M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$27.01M derived: sum of 2 quarters · filed 2018-03-15 | -$91.47M derived: sum of 3 quarters · filed 2018-03-15 | $36.81M 10-K · filed 2018-03-15 | ||||||||||
| 2015-09-30 | -$19.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$83.86M derived: sum of 2 quarters · filed 2016-11-03 | $44.43M 10-Q · filed 2016-11-03 | $38.72M derived: sum of 4 quarters · filed 2017-03-02 | ||||||||||
| 2015-06-30 | -$64.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $63.82M 10-Q · filed 2016-08-04 | $58.11M derived: sum of 3 quarters · filed 2017-03-02 | $53.69M derived: sum of 4 quarters · filed 2017-03-02 | ||||||||||
| 2015-03-31 | $128.28M 10-Q · filed 2016-05-05 | $122.57M derived: sum of 2 quarters · filed 2017-03-02 | $118.14M derived: sum of 3 quarters · filed 2017-03-02 | $78.56M derived: sum of 4 quarters · filed 2017-03-02 | ||||||||||
| 2014-12-31 | -$5.71M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | -$10.14M derived: sum of 2 quarters · filed 2017-03-02 | -$49.72M derived: sum of 3 quarters · filed 2017-03-02 | -$11.66M 10-K · filed 2017-03-02 | ||||||||||
| 2014-09-30 | -$4.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$44.01M derived: sum of 2 quarters · filed 2015-11-05 | -$5.95M 10-Q · filed 2015-11-05 | -$8.95M derived: sum of 4 quarters · filed 2016-02-26 | ||||||||||
| 2014-06-30 | -$39.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$1.52M 10-Q · filed 2015-08-10 | -$4.52M derived: sum of 3 quarters · filed 2016-02-26 | -$11.64M derived: sum of 4 quarters · filed 2016-02-26 | ||||||||||
| 2014-03-31 | $38.06M 10-Q · filed 2015-05-11 | $35.06M derived: sum of 2 quarters · filed 2016-02-26 | $27.94M derived: sum of 3 quarters · filed 2016-02-26 | $12.95M derived: sum of 4 quarters · filed 2016-02-26 | $56.13M 10-Q · filed 2014-05-08 | |||||||||
| 2013-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$10.12M derived: sum of 2 quarters · filed 2016-02-26 | -$25.11M derived: sum of 3 quarters · filed 2016-02-26 | $3.30M 10-K · filed 2016-02-26 | $18.08M 10-K · filed 2014-02-27 | |||||||||
| 2013-09-30 | -$7.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$22.11M derived: sum of 2 quarters · filed 2014-11-10 | $6.30M 10-Q · filed 2014-11-10 | -$14.04M derived: sum of 4 quarters · filed 2015-03-16 | $21.08M 10-Q · filed 2013-11-13 | |||||||||
| 2013-06-30 | -$14.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $13.42M 10-Q · filed 2014-08-07 | -$6.93M derived: sum of 3 quarters · filed 2015-03-16 | -$5.87M derived: sum of 4 quarters · filed 2015-03-16 | $28.19M 10-Q · filed 2013-08-13 | |||||||||
| 2013-03-31 | $28.41M 10-Q · filed 2014-05-08 | $8.07M derived: sum of 2 quarters · filed 2015-03-16 | $9.12M derived: sum of 3 quarters · filed 2015-03-16 | $4.90M derived: sum of 4 quarters · filed 2015-03-16 | $43.19M 10-Q · filed 2013-05-15 | |||||||||
| 2012-12-31 | -$20.34M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$19.29M derived: sum of 2 quarters · filed 2015-03-16 | -$23.51M derived: sum of 3 quarters · filed 2015-03-16 | $10.23M 10-K · filed 2015-03-16 | $14.78M 10-K · filed 2013-02-25 | |||||||||
| 2012-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$3.17M derived: sum of 2 quarters · filed 2013-11-13 | $30.58M 10-Q · filed 2013-11-13 | $35.12M 10-Q · filed 2012-11-13 | ||||||||||
| 2012-06-30 | -$4.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $29.53M 10-Q · filed 2013-08-13 | $34.07M 10-Q · filed 2012-08-14 | |||||||||||
| 2012-03-31 | $33.74M 10-Q · filed 2013-05-15 | |||||||||||||
| 2011-12-31 | $4.54M 10-K · filed 2014-02-27 | |||||||||||||
| 2011-09-30 | $5.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-13 | $5.59M 10-Q · filed 2012-11-13 | ||||||||||||
| 2011-06-30 | $7.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |